Last reviewed · How we verify
NCT04745806
Post Marketing Trial for Evaluating the Effectiveness of ActiGraft in Treating Lower Extremity Hard To Heal Wounds
NA trial testing ActiGraft in Wounds in 6 participants. Terminated before completion.
1 January 2023
Quick facts
| Lead sponsor | RedDress Ltd. |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 6 |
| Start date | 1 March 2021 |
| Primary completion | 1 January 2023 |
| Estimated completion | 1 January 2023 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- ActiGraft
Conditions studied
- Wounds — all drugs for Wounds →
Sponsor
RedDress Ltd.
Who can join
18 and older, any sex, with Wounds. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is a prospective, single arm, post- marketing study. The subjects enrolled to the study will receive weekly applications of ActiGraft until complete healing or until investigator's decision that patient can no longer benefit from the study treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04745806
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ActiGraft
Trials testing the same drug.
- NCT04899466 — Efficacy Evaluation of ActiGraft in Secondary Closure of Abdominal Surgical Wound Dehiscence · NA · recruiting
- NCT04185558 — Safety and Efficacy of ActiGraft Pro Compared to Standard of Care in DFUs · NA · completed
- NCT04699305 — Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers · recruiting
Other recruiting trials for Wounds
Currently open trials in the same condition.
- NCT06921707 — Pilot Trial for WounDx™ Clinical Decision Support Tool · NA · recruiting
- NCT05608317 — A Clinical Investigation to Follow the Progress of Exuding Chronic Venous Leg Ulcers Using a Non-Bordered Foam Dressing · NA · recruiting
Other RedDress Ltd. trials
Trials by the same sponsor.
- NCT05641844 — A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal · NA · recruiting
- NCT04899466 — Efficacy Evaluation of ActiGraft in Secondary Closure of Abdominal Surgical Wound Dehiscence · NA · recruiting
- NCT04185558 — Safety and Efficacy of ActiGraft Pro Compared to Standard of Care in DFUs · NA · completed
- NCT04699305 — Safety and Efficacy of ActiGraft Treatment in Wound Care in Medical Centers · recruiting
- NCT04577183 — A Prospective, Open Label, Multicenter Trial for Evaluating the Efficacy of Treating and Managing Wounds in Elderly Popu · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04745806 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RedDress Ltd.
- Last refreshed: 15 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04745806.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing